857 related items for PubMed ID: 12911449
1. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[Abstract] [Full Text] [Related]
2. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[Abstract] [Full Text] [Related]
3. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Jolly EE, Bjarnason NH, Neven P, Plouffe L, Johnston CC, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.
Menopause; 2003 Dec; 10(4):337-44. PubMed ID: 12851517
[Abstract] [Full Text] [Related]
4. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
Bunyavejchevin S, Limpaphayom KK.
J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
[Abstract] [Full Text] [Related]
5.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
6. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
Menopause; 2006 Jan; 13(4):643-50. PubMed ID: 16837886
[Abstract] [Full Text] [Related]
7. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
[Abstract] [Full Text] [Related]
8. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
Greenwald MW, Gluck OS, Lang E, Rakov V.
Menopause; 2005 Dec; 12(6):741-8. PubMed ID: 16278618
[Abstract] [Full Text] [Related]
9. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S, Caubel P, Garnero P, Felsenberg D.
Maturitas; 2004 Jul 15; 48(3):197-207. PubMed ID: 15207885
[Abstract] [Full Text] [Related]
10. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR.
Maturitas; 2008 Jan 20; 59(1):2-6. PubMed ID: 18063490
[Abstract] [Full Text] [Related]
11. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
Metabolism; 2009 Jan 20; 58(1):1-7. PubMed ID: 19059524
[Abstract] [Full Text] [Related]
12. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
Falkeborn M, Lithell H, Persson I, Vessby B, Naessén T.
Climacteric; 2002 Sep 20; 5(3):240-8. PubMed ID: 12419082
[Abstract] [Full Text] [Related]
13. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C.
N Engl J Med; 1997 Dec 04; 337(23):1641-7. PubMed ID: 9385122
[Abstract] [Full Text] [Related]
14. Association between serum cholesterol and bone mineral density.
Makovey J, Chen JS, Hayward C, Williams FM, Sambrook PN.
Bone; 2009 Feb 04; 44(2):208-13. PubMed ID: 18983946
[Abstract] [Full Text] [Related]
15. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
Popp AW, Bodmer C, Senn C, Fuchs G, Kraenzlin ME, Wyss H, Birkhaeuser MH, Lippuner K.
Maturitas; 2006 Jan 20; 53(2):191-200. PubMed ID: 16368472
[Abstract] [Full Text] [Related]
16. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
Warming L, Ravn P, Christiansen C.
Maturitas; 2005 Feb 14; 50(2):78-85. PubMed ID: 15653003
[Abstract] [Full Text] [Related]
17. The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
Bassol S, Carranza-Lira S, Celis-Gonzalez C, Santoyo S, Murillo A, Martinez N, Santos J, Llaca V, de la Loza FR, Zarain J, da Fonseca AM, Camargos AF, Baracat EC, da Sá MF, Bayo J, Adaro L, Gurucharri C, Murga M, Siseles N, Sayegh F, Tempone A, Tempone LM, Tozzini RI, Boccanera R, Naranjo C, Sanchez F, Gomez G, Blanco S, Reyes-Marquez R, Albrecht G, Rios PC.
Maturitas; 2005 Mar 14; 50(3):189-95. PubMed ID: 15734600
[Abstract] [Full Text] [Related]
18. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K.
Chin Med J (Engl); 2004 Jul 14; 117(7):1029-35. PubMed ID: 15265377
[Abstract] [Full Text] [Related]
19. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
Tuppurainen M, Härmä K, Komulainen M, Kiviniemi V, Kröger H, Honkanen R, Alhava E, Jurvelin J, Saarikoski S.
Maturitas; 2010 Aug 14; 66(4):423-30. PubMed ID: 20547017
[Abstract] [Full Text] [Related]
20. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
Dane C, Dane B, Cetin A, Erginbas M.
Gynecol Endocrinol; 2007 Jul 14; 23(7):398-403. PubMed ID: 17701771
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
